
Study: Weight-Loss Drugs Reduce Body Weight but Do Not Improve Quality of Life

Microdosing GLP-1 weight-loss drugs: Experts urge caution despite growing trend

Scientists Move Closer to a Type 1 Diabetes Treatment Without Lifelong Immune Suppression

Scientists Assess How Cardiovascular Risks in Obesity Have Changed Over the Past 30 Years

Routine Eye Exams May Detect Dangerous High Blood Pressure in People with Diabetes

Century-Old Tuberculosis Vaccine Shows Promise in Diabetes Trial

Finerenone for Chronic Kidney Disease: New Evidence Suggests Benefits Beyond Diabetes

FLOW Study: Semaglutide Improves Quality of Life in Patients with Diabetes and Chronic Kidney Disease

New Experimental Pill May Burn Fat Without the Drawbacks of Ozempic

Singapore Researchers Develop Faster Method to Identify Treatments for Diabetic Wounds

New AI Tool Learns to Predict Type 1 Diabetes Risk More Accurately Using Genetics

Dual Benefit: Diabetes Drug May Help Treat Alcohol Use Disorder

Turmeric Against Diabetes Complications: What a New Study Found

Long-term uveitis risk in GLP-1 users appears higher in women than in men

Oranges vs. Liver Disease: Effect Turned Out Weaker Than Scientists Expected

ES: Ketogenic Diet May Improve Pancreatic Function in Patients With Type 2 Diabetes

Reddit Users Highlight Possible GLP-1 Side Effects Missed in Clinical Trials

An Unexpected Factor in Lowering Blood Sugar Levels Revealed

Blueberry Extract May Ease Gestational Diabetes via Gut Microbiota

Regular Morning Exercise Lowers Risk of Heart Disease and Diabetes — New Scientific Analysis

OR: Metformin may reduce the risk of age-related macular degeneration

Natural remedy found to reduce the risk of diabetes

Common Habit Linked to Diabetes Risk in Offspring

Cardiovascular Diabetology: Puberty Can “Reprogram” Gene Activity and Diabetes Risk

BMJ: About 7 hours and 18 minutes of sleep per night is linked to a lower risk of diabetes

Frontiers in Nutrition: Regularly skipping breakfast associated with metabolic syndrome

Novo Nordisk to Invest Up to $2.1 Billion in Development of Next-Generation Drugs for Obesity and Diabetes

NatCom: Type 2 Diabetes and Hypertension Linked by Five Groups of Genetic Variants

Nature Communications: Type 2 Diabetes and Hypertension Share a Common Genetic Mechanism

Kidney International: Some diabetes drugs may slow kidney aging